Cargando…
Dysregulation of prostaglandins, leukotrienes and lipoxin A(4) in bronchiectasis
INTRODUCTION: Bronchiectasis is characterised by excessive neutrophilic inflammation. Lipid mediators such as prostaglandins and leukotrienes have crucial roles in the inflammatory response. Further characterisation of these lipids and understanding the interplay of anti-inflammatory and proinflamma...
Autores principales: | Bedi, Pallavi, Ziegler, Kerstin, Whitfield, Phil D, Davidson, Donald, Rossi, Adriano Giorgio, Hill, Adam T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510413/ https://www.ncbi.nlm.nih.gov/pubmed/34789559 http://dx.doi.org/10.1136/thoraxjnl-2020-216475 |
Ejemplares similares
-
Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis)
por: Hill, Andrew R., et al.
Publicado: (2023) -
‘It’s not one size fits all’: a qualitative study of patients’ and healthcare professionals’ views of self-management for bronchiectasis
por: Kelly, Carol Ann, et al.
Publicado: (2021) -
Feasibility of home initiation of an airway clearance device (SIMEOX) by telecare in people with non-cystic fibrosis bronchiectasis: a pilot study
por: Hamidfar, Rebecca, et al.
Publicado: (2023) -
Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
por: Rømer, Valdemar, et al.
Publicado: (2023) -
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
por: Serisier, David J, et al.
Publicado: (2013)